The significance of BLM, AHCY, PKMYT1, and CKS1B in the pathogenesis of neuroblastoma is indicated by their elevated expression in MYCN-amplified tumor samples and in MYCN-overexpressing cells and their correlation with poor patient survival (Fig. 5, A–C). This evidence concerns the gene MYCN and neuroblastoma.